knowledge -WSS

knowledge

author：explore 2025-09-30 23:19:50 - browse：6

Light at the end of a hospital corridor, where an empty gurney parked — health tech coverage from STAT — Adobe

Health professor Neil Wenger was deep into a years-long study on seriously ill primary care patients when he uncovered a different but persistent issue: Many patients who were targeted for follow-up interventions had actually died, and their hospitals did not know about it.

It wasn’t what Wenger had set out to research. But it was unacceptable, he said, for health systems to lose track of seriously ill primary care patients who’d been treated on-site for years. To be clear, these were not one-time out-of-state patients who’d come in for a single visit.

“When I found a bunch of them were dead and we didn’t actually know it, that’s when I said we need to describe it,” he said. “This is a cohort where we need to know about everyone who is dead.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How AI helped researchers track recovery from depression

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Intarcia’s device

Health and fitness trackers are measuring the wrong things

What Congress can do to address the rural doctor shortage

Fauci’s Covid grilling leads GOP to weigh foreign research rules

As JPM 2024 winds down, some health tech firms project optimism

hotspot

knowledge

entertainment

New air purifier tech could be key to improving indoor air quality

Emergency workers more likely to restrain Black patients: study

Medicare details structure of new drug price negotiation program

How I ended up pumping milk in a bathroom stall at JPM 2024

At least 13 dead in Texas as scorching temps continue

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

As demand for Covid shots wanes, Moderna seeks its next success

Lasker Awards 2023: Winners in biomedical research

Walensky prepares to leave CDC — and Congress — behind

Experts study whether long Covid risk adds up with each reinfection

focus

JPM 2024: Verve Therapeutics looks to mainstream genome editing

STAT Virtual Event: Putting AI to the Test

How Vertex's cystic fibrosis drug is changing patients' lives

Drug for rare kidney disease narrowly misses mark in clinical trial

New Medicare drug pricing powers could soon be upended in court

Three issues to watch in global health in 2024

entertainment

explore

hotspot

entertainment